- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07648862
Comparing Post Operative Pain With and Without Apical Patency Technique in Asymptomatic Irreversible Pulpitis Teeth
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Dr. Misbah Principal Investigator, BDS FCPS
- Phone Number: +92-334-1364014
- Email: khanmusbah@gmail.com
Study Locations
-
-
Balochistan
-
Quetta, Balochistan, Pakistan, 87300
- Department of Operative Dentistry, Bolan Medical Complex Hospital Unit 2
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria Age 20-50 years; maxillary or mandibular first/second premolar; diagnosed with asymptomatic irreversible pulpitis (no history of spontaneous pain; caries extending ≥2/3 into dentine; no tenderness to percussion/palpation; exaggerated, prolonged response to pulp vitality testing - cold, hot, or EPT)
Exclusion Criteria Uncontrolled diabetes mellitus; uncontrolled hypertension; bleeding disorder; use of anticoagulant therapy; active peptic ulcer; ischemic heart disease; compromised hepatic or renal function; immature apex; internal or external root resorption; blocked or sclerosed canal; periapical radiolucency; acute apical periodontitis; grade 3 mobility; root fracture; teeth in which patency cannot be maintained; symptomatic irreversible pulpitis; non-restorable teeth; retreatment cases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Apical Patency Group
Arm 1 - Apical Patency Group (APG) A #10 K-file is passed 0.5 mm beyond working length after each rotary instrument
|
After each rotary instrument, a pre-curved #10 K-file was passively passed 0.5 mm beyond the working length.
No filing motion was performed.
|
|
Active Comparator: Non-Patency Group
Arm 2 - Non-Patency Group (NPG) Recapitulation confined to working length only; no instrument passed beyond apex
|
No instrument was intentionally passed beyond the working length.
Recapitulation was performed only to the working length.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Primary Outcome - Measure Presence of postoperative pain
Time Frame: 24 hours post-treatment
|
Postoperative pain assessed using the Numerical Rating Scale (NRS), categorized as present (NRS ≥1) or absent (NRS = 0)
|
24 hours post-treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intensity Over Time
Time Frame: 6, 12, 24, 48, and 72 hours after completion of root canal treatment
|
Outcome Measure Description Mean post-operative pain intensity measured on the Numerical Rating Scale (0-10, where 0=no pain and 10=worst pain imaginable).
Assessed at multiple time points: 6, 12, 24, 48, and 72 hours after root canal treatment.
|
6, 12, 24, 48, and 72 hours after completion of root canal treatment
|
|
6, 12, 24, 48, and 72 hours after completion of root canal treatment
Time Frame: Up to 72 hours after completion of root canal treatment
|
Time in hours from completion of root canal treatment until the participant achieves a pain-free state (Numerical Rating Scale score = 0).
|
Up to 72 hours after completion of root canal treatment
|
Collaborators and Investigators
Investigators
- Study Chair: Dr Syed Attaullah Shah, BDS, Fcps, Bolan medical College sandeman Provisional hospital Quetta
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- BolanMed
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.